Parkinson’s disease

What is Parkinson's disease?

Parkinson’s occurs when nerve cells in the substantia nigra stop producing enough dopamine, the chemical messenger responsible for smooth, coordinated movement. As dopamine levels drop, physical actions become slower, stiffer, and less controlled.

The disease's hallmark is the accumulation of Lewy bodies (protein deposits) in the brain. This pathological process begins years, sometimes decades, before physical tremors appear, often affecting sleep, mood, and digestion first.

Because Parkinson’s exists on a broad spectrum, symptom patterns and progression rates vary significantly between individuals. While not immediately life-threatening, identifying these neurological shifts early is essential for maintaining mobility, energy, and long-term quality of life.

Common symptoms of Parkinson's disease

Parkinson's symptoms are divided into motor and non-motor categories. Non-motor symptoms frequently appear first and are often overlooked or attributed to other causes.

Non-motor symptoms:

• Loss of smell (hyposmia or anosmia)

• REM sleep behaviour disorder — physically acting out vivid dreams

• Constipation

• Depression and anxiety

• Fatigue and cognitive slowing

• Orthostatic hypotension (dizziness on standing from autonomic dysfunction)

Motor symptoms:

• Resting tremor — typically beginning in one hand

• Bradykinesia — slowness of movement; reduced arm swing, shuffling gait

• Muscle rigidity — stiffness throughout the range of motion

• Postural instability — balance difficulties, increasing fall risk

• Small handwriting (micrographia) and reduced facial expression (hypomimia)

• Softened or monotone speech

Symptoms typically begin on one side and gradually become bilateral over time.

What causes Parkinson's disease?

The exact cause of Parkinson’s disease isn’t fully understood, but several factors may contribute:

• Genetic predisposition: Certain inherited changes can slightly increase risk.

• Age: Most cases appear after age 60, though early-onset Parkinson’s can occur earlier.

• Environmental exposure: Long-term contact with certain chemicals or toxins may play a role.

• Oxidative stress and cellular imbalance: Damage to brain cells from stress and inflammation is being actively studied.

While these risks can’t always be avoided, early awareness helps in managing overall brain health through balanced lifestyle habits.

How is Parkinson's disease detected?

Parkinson’s is a clinical diagnosis, meaning no single test confirms it. However, diagnostics are essential to rule out "Parkinsonisms", conditions that mimic its symptoms but require different treatments.

Brain MRI: MRI cannot diagnose Parkinson's directly, but it is essential for excluding structural mimics such as Normal Pressure Hydrocephalus (fluid buildup), Vascular Parkinsonism (small strokes), or brain tumors. It also helps identify atypical syndromes like Multiple System Atrophy.

Elfcare's full body MRI includes detailed brain imaging as standard — making it directly relevant to identifying or excluding these structural mimics.

Blood tests cannot detect Parkinson's but identify metabolic contributors and rule out conditions causing similar symptoms. Relevant markers in Elfcare's panel include:

• Vitamin B12 & Folate: Deficiency can cause tremors and cognitive slowing that mimic or worsen neurological decline.

• Homocysteine: High levels are linked to accelerated brain aging and neurodegeneration.

• Thyroid Panel (TSH/T3/T4): Thyroid dysfunction frequently causes stiffness and tremors that appear parkinsonian.

• Ferritin: High iron levels are associated with oxidative stress in the brain's movement centers.

• CRP: systemic inflammation; neuroinflammation is increasingly recognised as a contributor to Parkinson's progression.

• HbA1c & Glucose: Metabolic health is closely linked to the risk and speed of neurological progression.

Why early detection matters

The neurodegeneration underlying Parkinson's begins years before motor symptoms appear. While there is currently no treatment that halts this process, early identification of structural mimics allows for treatment of reversible conditions.

Early identification of metabolic risk factors such as B12 deficiency, thyroid dysfunction and elevated homocysteine, allows for correction that supports neurological health. And early specialist referral, when Parkinson's is clinically suspected, enables treatment that significantly improves quality of life and functional independence for longer.

How Elfcare can help

Elfcare focuses on early detection and empowerment. Our approach identifies the structural and metabolic factors that influence brain health, helping you distinguish between primary neurological conditions and treatable imbalances.

Elfcare's brain MRI can identify structural causes of parkinsonian symptoms, including normal pressure hydrocephalus, vascular changes, and other conditions that are treatable and must be excluded before a Parkinson's diagnosis is considered.

Our blood panel rules out metabolic mimics such as thyroid dysfunction, B12 deficiency, and elevated homocysteine and identifies the systemic factors most closely linked to neurological vulnerability.

Elfcare cannot diagnose Parkinson’s disease; that requires a specialist neurological assessment. However, if our tests identify a structural or metabolic irregularity, we manage your follow-up diagnostics and provide a direct referral to a specialist to ensure you get the right care early.